Bi- and tri-cyclic aza compounds and their uses
AssigneeGeorgetown University
InventorsAlan P. Kozikowski, Miles P. Smith
Life of this patent
Estimating the term…
Abstract
The present invention provides tropane-derived monoamine neurotransmitter re-uptake inhibitors which predictably exhibit selectivity for either the serotonin or dopamine transporter, pharmaceutical compositions thereof and methods for their use. The serotonin-selective re-uptake inhibitors are particularly useful for treating neurological disorders associated with the serotonergic neural system of the brain, such as depression, with significantly reduced side-effects. The dopamine-selective re-uptake inhibitors are particularly useful for treating disorders associated with dopamine re-uptake and/or acetylcholine release.
Claims30
A compound, or a pharmaceutically acceptable salt thereof, having the structure:
- ##STR59## wherein:
- W.sub.1 and W.sub.2 taken together form .dbd.O, .dbd.S, .dbd.NOR.sub.3, .dbd.N--CN, .dbd.N--NR.sub.3 R.sub.4, .dbd.CR.sub.3 R.sub.4 or (C.sub.3 -C.sub.8) alkeno, or
- W.sub.1 and W.sub.2 are each independently selected from the group consisting of --H, halogen, --OR.sub.3, --SR.sub.3, --N--NR.sub.3 R.sub.4 or --(CH.sub.2).sub.o --O--(CH.sub.2).sub.o -R.sub.7 where each o is independently 0, 1, 2 or 3;
- R.sub.1 is phenyl or phenyl independently substituted with one or more R.sub.6 ;
- R.sub.2 is --H, (C.sub.2 -C.sub.6) alkyl, (C.sub.2 -C.sub.6) alkenyl, (C.sub.2 -C.sub.6) alkynyl, (C.sub.5 -C.sub.20) aryl, 5-20 membered heteroaryl or --(CH.sub.2).sub.q --O--(CH.sub.2).sub.q --R.sub.7 where each q is independently 0, 1, 2 or 3;
- R.sub.3 and R.sub.4 are each independently selected from the group consisting of --H, (C.sub.1 -C.sub.6) alkyl, (C.sub.2 -C.sub.6) alkenyl, (C.sub.2 -C.sub.6) alkynyl, (C.sub.5 -C.sub.20) aryl, (C.sub.5 -C.sub.20) aryl independently substituted with one or more R.sub.6, 6-26 membered heteroaryl and 6-26 membered heteroaryl independently substituted with one or more R.sub.6 ;
- each R.sub.6 is independently selected from the group consisting of halogen, --CF.sub.3, --CN, (C.sub.1 -C.sub.6) alkyl, (C.sub.2 -C.sub.6) alkenyl, (C.sub.2 -C.sub.6) alkynyl, (C.sub.1 -C.sub.6) alkoxy and (C.sub.3 -C.sub.6) cycloalkoxy;
- and
- R.sub.7 is (C.sub.5 -C.sub.20) aryl, (C.sub.5 -C.sub.20) aryl independently substituted with one or more R.sub.6, 5-20 membered heteroaryl and 5-20 membered heteroaryl independently substituted with one or more R.sub.6.
Dependencies are inferred from the claim text.